Mark For: DYAX® trademark registration is intended to cover the categories of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 76123428 |
Registration Number | 2710452 |
Mark Literal Elements | DYAX |
Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
Mark Type | TRADEMARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Affidavit Text | SECT 15. SECT 8 (6-YR). |
Current Location | POST REGISTRATION 2009-05-08 |
Basis | 1(a) |
Class Status | SECTION 8 - CANCEL |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | Yes |
Intent To Use | No |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Cancellation Code | 2 |
Attorney Name | Patrick J. Concannon |
Attorney Docket Number | 202403-0022 |
Law Office Assigned | M60 |
Employee Name | CLARK, GLENN G |
2000-09-06 | Application Filed |
2002-06-11 | Date of First Use |
2002-06-11 | Date of Use In Commerce |
2003-02-04 | Published |
2003-02-04 | Published for Opposition |
2003-04-29 | Trademark Registered |
2009-05-08 | Location: POST REGISTRATION |
2013-12-06 | Cancelled |
2013-12-06 | Status: Dead/Cancelled |
2013-12-06 | Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this |
2018-07-08 | Transaction Date |
Party: | ![]() |
Address | 300 Technology Square Cambridge, MASSACHUSETTS UNITED STATES 02139 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
![]() | IMAGE/TIFF | 2000-09-06 |
![]() | IMAGE/TIFF | 2000-09-06 |
![]() | 2002-11-01 | |
![]() | 2002-11-01 | |
![]() | 2003-01-15 | |
![]() | 2003-04-29 | |
![]() | 2003-04-29 | |
![]() | 2008-01-17 | |
![]() | 2008-01-17 | |
![]() | 2008-01-17 | |
![]() | 2009-04-27 | |
![]() | 2009-04-27 | |
![]() | 2009-05-08 | |
![]() | 2011-10-23 |
(CANCELLED)
IC 005. US 006 018 044 046 051 052. G & S: pharmaceutical compound for use in the treatment and/or prevention of inflammation in genetic, cardiovascular, pulmonary, oncologic, and rheumatoid diseases and complications of surgical or interventional procedures. FIRST USE: 20020611. FIRST USE IN COMMERCE: 20020611
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | pharmaceutical compound for use in the treatment and/or prevention of inflammation in genetic, cardiovascular, pulmonary, oncologic, and rheumatoid diseases and complications of surgical or interventional procedures |
Description | Date | Proceeding Number |
---|---|---|
CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | 2013-12-06 | 59136 |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2011-10-23 | |
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2009-05-08 | 59136 |
ASSIGNED TO PARALEGAL | 2009-04-28 | 59136 |
TEAS SECTION 8 & 15 RECEIVED | 2009-04-27 | |
CASE FILE IN TICRS | 2008-01-22 | |
REGISTERED-PRINCIPAL REGISTER | 2003-04-29 | |
PUBLISHED FOR OPPOSITION | 2003-02-04 | |
NOTICE OF PUBLICATION | 2003-01-15 | |
USE AMENDMENT ACCEPTED | 2002-12-03 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2002-12-03 | |
AMENDMENT TO USE PROCESSING COMPLETE | 2002-11-29 | |
USE AMENDMENT FILED | 2002-11-01 | |
PAPER RECEIVED | 2002-11-01 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2002-11-01 | |
ASSIGNED TO EXAMINER | 2002-10-17 | 69191 |
PREVIOUS ALLOWANCE COUNT WITHDRAWN | 2002-01-28 | |
LETTER OF SUSPENSION MAILED | 2002-01-28 | |
NOTICE OF ALLOWANCE CANCELLED | 2002-01-23 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2001-12-28 | |
NOA MAILED - SOU REQUIRED FROM APPLICANT | 2001-09-04 | |
PUBLISHED FOR OPPOSITION | 2001-06-12 | |
NOTICE OF PUBLICATION | 2001-05-30 | |
ASSIGNED TO EXAMINER | 2001-02-08 | 78190 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2001-02-08 | |
ASSIGNED TO EXAMINER | 2001-01-23 | 76746 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.